重大事件
即時報告
8-K
2026-06-05
Gossamer Bio提交8-K 股東表決結果待公布
AI 繁中摘要
Gossamer Bio, Inc.（股票代號：GOSS）於2026年6月4日向美國證監會提交8-K表格，報告股東表決事項（Item 5.07）。申報文件未披露具體議案內容或投票結果，但本次8-K的提交表明公司已舉行股東投票，並按規定即時披露。投資者應關注後續正式投票結果公告，以了解股東對公司重大事項（如董事選舉、薪酬計劃或潛在授權）的取態。
展開英文正文
EDGAR Filing Documents for 0001728117-26-000042 SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001728117-26-000042 Filing Date 2026-06-05 Accepted 2026-06-04 17:34:07 Documents 11 Period of Report 2026-06-04 Items Item 5.07: Submission of Matters to a Vote of Security Holders Interactive Data Document Format Files Seq Description Document Type Size 1 8-K goss-20260604.htm iXBRL 8-K 38579 Complete submission text file 0001728117-26-000042.txt 156439 Data Files Seq Description Document Type Size 2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT goss-20260604.xsd EX-101.SCH 1794 3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT goss-20260604_lab.xml EX-101.LAB 22532 4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT goss-20260604_pre.xml EX-101.PRE 13051 14 EXTRACTED XBRL INSTANCE DOCUMENT goss-20260604_htm.xml XML 2858 Mailing Address 3115 MERRYFIELD ROW SUITE 120 SAN DIEGO CA 92121 Business Address 3115 MERRYFIELD ROW SUITE 120 SAN DIEGO CA 92121 (858) 684-1300 Gossamer Bio, Inc. (Filer) CIK: 0001728117 (see all company filings) EIN.: 475461709 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-38796 | Film No.: 261066141 SIC: 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)